Drug Shortage Report for GLYCOPYRROLATE INJECTION USP
| Report ID | 200632 |
| Drug Identification Number | 02473879 |
| Brand name | GLYCOPYRROLATE INJECTION USP |
| Common or Proper name | GLYCOPYRROLATE INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLYCOPYRROLATE |
| Strength(s) | 0.2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 x 1 mL vials |
| ATC code | A03AB |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-07-03 |
| Estimated end date | 2023-09-29 |
| Actual end date | 2023-09-29 |
| Shortage status | Resolved |
| Updated date | 2023-09-30 |
| Company comments | Product is now available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-09-30 | English | Compare |
| v6 | 2023-09-29 | French | Compare |
| v5 | 2023-09-29 | English | Compare |
| v4 | 2023-08-24 | French | Compare |
| v3 | 2023-08-24 | English | Compare |
| v2 | 2023-08-01 | French | Compare |
| v1 | 2023-08-01 | English | Compare |
Showing 1 to 7 of 7